171 related articles for article (PubMed ID: 34782395)
1. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
Man TK; Aubert G; Richard MA; LeJeune W; Hariri E; Goltsova T; Gaikwad A; Chen Y; Whitton J; Leisenring WM; Arnold MA; Neglia JP; Yasui Y; Robison LL; Armstrong GT; Bhatia S; Gramatges MM
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):453-460. PubMed ID: 34782395
[TBL] [Abstract][Full Text] [Related]
2. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
[TBL] [Abstract][Full Text] [Related]
3. Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS).
Gramatges MM; Morton LM; Yasui Y; Arnold MA; Neglia JP; Leisenring WM; Machiela MJ; Dagnall CL; Chanock SJ; Armstrong GT; Robison LL; Bhatia S; Lupo PJ
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):417-419. PubMed ID: 30377209
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
[TBL] [Abstract][Full Text] [Related]
5. Shortened Leukocyte Telomere Length Associates with an Increased Prevalence of Chronic Health Conditions among Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort.
Song N; Li Z; Qin N; Howell CR; Wilson CL; Easton J; Mulder HL; Edmonson MN; Rusch MC; Zhang J; Hudson MM; Yasui Y; Robison LL; Ness KK; Wang Z
Clin Cancer Res; 2020 May; 26(10):2362-2371. PubMed ID: 31969337
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
7. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract][Full Text] [Related]
8. Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging.
Ariffin H; Azanan MS; Abd Ghafar SS; Oh L; Lau KH; Thirunavakarasu T; Sedan A; Ibrahim K; Chan A; Chin TF; Liew FF; Jeyamogan S; Rosli ES; Baharudin R; Yap TY; Skinner R; Lum SH; Hainaut P
Cancer; 2017 Nov; 123(21):4207-4214. PubMed ID: 28654149
[TBL] [Abstract][Full Text] [Related]
9. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study.
Sigurdson AJ; Ronckers CM; Mertens AC; Stovall M; Smith SA; Liu Y; Berkow RL; Hammond S; Neglia JP; Meadows AT; Sklar CA; Robison LL; Inskip PD
Lancet; 2005 Jun 11-17; 365(9476):2014-23. PubMed ID: 15950715
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study.
Campa D; Mergarten B; De Vivo I; Boutron-Ruault MC; Racine A; Severi G; Nieters A; Katzke VA; Trichopoulou A; Yiannakouris N; Trichopoulos D; Boeing H; Quirós JR; Duell EJ; Molina-Montes E; Huerta JM; Ardanaz E; Dorronsoro M; Khaw KT; Wareham N; Travis RC; Palli D; Pala V; Tumino R; Naccarati A; Panico S; Vineis P; Riboli E; Siddiq A; Bueno-de-Mesquita HB; Peeters PH; Nilsson PM; Sund M; Ye W; Lund E; Jareid M; Weiderpass E; Duarte-Salles T; Kong SY; Stepien M; Canzian F; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2447-54. PubMed ID: 25103821
[TBL] [Abstract][Full Text] [Related]
12. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
13. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
14. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
[TBL] [Abstract][Full Text] [Related]
15. Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
Wang Z; Wilson CL; Easton J; Thrasher A; Mulder H; Liu Q; Hedges DJ; Wang S; Rusch MC; Edmonson MN; Levy S; Lanctot JQ; Caron E; Shelton K; Currie K; Lear M; Patel A; Rosencrance C; Shao Y; Vadodaria B; Yergeau D; Sapkota Y; Brooke RJ; Moon W; Rampersaud E; Ma X; Chang TC; Rice SV; Pepper C; Zhou X; Chen X; Chen W; Jones A; Boone B; Ehrhardt MJ; Krasin MJ; Howell RM; Phillips NS; Lewis C; Srivastava D; Pui CH; Kesserwan CA; Wu G; Nichols KE; Downing JR; Hudson MM; Yasui Y; Robison LL; Zhang J
J Clin Oncol; 2018 Jul; 36(20):2078-2087. PubMed ID: 29847298
[TBL] [Abstract][Full Text] [Related]
16. Obesity and Risk for Second Malignant Neoplasms in Childhood Cancer Survivors: A Case-Control Study Utilizing the California Cancer Registry.
Moke DJ; Hamilton AS; Chehab L; Deapen D; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1612-1620. PubMed ID: 31337641
[TBL] [Abstract][Full Text] [Related]
17. Paternal age at birth is associated with offspring leukocyte telomere length in the nurses' health study.
Prescott J; Du M; Wong JY; Han J; De Vivo I
Hum Reprod; 2012 Dec; 27(12):3622-31. PubMed ID: 22940768
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis.
Chen M; Xu Y; Xu J; Chancoco H; Gu J
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):203-209. PubMed ID: 32998948
[TBL] [Abstract][Full Text] [Related]
19. Cumulative lifetime stress exposure and leukocyte telomere length attrition: The unique role of stressor duration and exposure timing.
Mayer SE; Prather AA; Puterman E; Lin J; Arenander J; Coccia M; Shields GS; Slavich GM; Epel ES
Psychoneuroendocrinology; 2019 Jun; 104():210-218. PubMed ID: 30884304
[TBL] [Abstract][Full Text] [Related]
20. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
Kovalchik SA; Ronckers CM; Veiga LH; Sigurdson AJ; Inskip PD; de Vathaire F; Sklar CA; Donaldson SS; Anderson H; Bhatti P; Hammond S; Leisenring WM; Mertens AC; Smith SA; Stovall M; Tucker MA; Weathers RE; Robison LL; Pfeiffer RM
J Clin Oncol; 2013 Jan; 31(1):119-27. PubMed ID: 23169509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
